Descriptions and definitions of data for data_file_for_The Ratio_Between_SARS-CoV-2.xlsx Each tab is organized by each figure panel. Column headings and their descriptions: --- FIG1A Relative collection time (days post enrollment): The time (in days) from when a participant was enrolled in the study. swab Viral load (N cp/mL): The viral load of SARS-CoV-2 in swab samples measured by N gene cp/mL. TCID50/mL: The tissue culture infection dose to infect 50% of test cultures (TCID50) for samples collected from nasal swabs. swab RNaseP: Cq vlaue of human RNaseP gene control in swab samples. saliva viral load (N cp/mL): The viral load of SARS-CoV-2 in saliva samples measured by N gene cp/mL. saliva RNaseP: Cq vlaue of human RNaseP gene control in saliva samples. E (cp/mL): The viral load of SARS-CoV-2 in swab samples measured by E gene cp/mL. RdRP (cp/mL): The viral load of SARS-CoV-2 in swab samples measured by RdRP gene cp/mL. --- FIG1B Each column reports the viral load (N cp/mL) in either nasal swab or saliva samples (top column label) in samples that were either positive (+) or negative (-) for culturable virus in nasal swab. --- FIG1C Relative collection time (days post enrollment): The time (in days) from when a participant was enrolled in the study. TCID50/N1: The ratio of TCID50 as measured from nasal swab samples relative to the N gene viral load (N cp/mL) in nasal samples for samples that were positive for culturable virus in nasal swab samples. --- FIGS1 Relative collection time (days post enrollment): The time (in days) from when a participant was enrolled in the study. swab Viral load (N cp/mL): The viral load of SARS-CoV-2 in swab samples measured by N gene cp/mL. TCID50/mL: The tissue culture infection dose to infect 50% of test cultures (TCID50) for samples collected from nasal swabs. swab RNaseP: Cq vlaue of human RNaseP gene control in swab samples. saliva viral load (N cp/mL): The viral load of SARS-CoV-2 in saliva samples measured by N gene cp/mL. saliva RNaseP: Cq vlaue of human RNaseP gene control in saliva samples. E (cp/mL): The viral load of SARS-CoV-2 in swab samples measured by E gene cp/mL. RdRP (cp/mL): The viral load of SARS-CoV-2 in swab samples measured by RdRP gene cp/mL. --- FIGS2A swab Viral load (N cp/mL): The viral load of SARS-CoV-2 in swab samples measured by N gene cp/mL. E (cp/mL): The viral load of SARS-CoV-2 in swab samples measured by E gene cp/mL. RdRP (cp/mL): The viral load of SARS-CoV-2 in swab samples measured by RdRP gene cp/mL. --- FIGS2B Relative collection time (days post enrollment): The time (in days) from when a participant was enrolled in the study. RdRP/E: The ratio of the viral loads of SARS-CoV-2 in swab samples measured by the RdRP gene and the E gene. E/N: The ratio of the viral loads of SARS-CoV-2 in swab samples measured by the E gene and the N gene. RdRP/N: The ratio of the viral loads of SARS-CoV-2 in swab samples measured by the RdRP gene and the N gene. --- FIGS3 Days from inoculation: time (in days) from when each participant was inoculated with SARS-CoV-2 in challenge study. Participant X: The ratio of viral titer to viral load (PFU/copies) for each participant in the challenge study. Average: The average value of the ratio of viral titer to viral load (PFU/copies) across each time point from days from inoculation. N observations: The number of observations observed at each time point from days from inoculation.